Anders Jack
SEC CIK 1800668 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | See Remarks | 119.2K | — | $9.91M | 44 | 2021-09-17 | 2026-09-16 |
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.19M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 18:00 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $199.24 | -4,053 | 119.2K | -3% | -$807.5K |
| DT | 2026-06-26 16:10 | 2026-06-24 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $18.56 | +20.0K | 143.3K | +16% | +$371.2K |
| DMT | 2026-06-26 16:10 | 2026-06-24 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $168.33 | -20.0K | 123.3K | -14% | -$3.37M |
| T | 2026-06-18 16:10 | 2026-06-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $156.12 | -2,722 | 123.3K | -2% | -$425.0K |
| T | 2026-03-19 | 2026-03-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $99.48 | -2,753 | 125.5K | -2% | -$273.9K |
| D | 2026-03-03 | 2026-03-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | A - Grant | $0.00 | +20.2K | 128.3K | +19% | $0 |
| DT | 2026-01-09 | 2026-01-07 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $98.00 | -10.0K | 108.1K | -8% | -$980.0K |
| DT | 2026-01-09 | 2026-01-07 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $42.45 | +10.0K | 118.1K | +9% | +$424.5K |
| T | 2025-12-18 | 2025-12-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $77.09 | -3,104 | 108.1K | -3% | -$239.3K |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $17.00 | +5,418 | 116.4K | +5% | +$92.1K |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $74.00 | -5,418 | 111.0K | -5% | -$400.9K |
| DT | 2025-11-13 | 2025-11-11 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $64.00 | -10.0K | 111.0K | -8% | -$640.0K |
| DT | 2025-11-13 | 2025-11-11 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $17.00 | +10.0K | 121.0K | +9% | +$170.0K |
| T | 2025-09-18 | 2025-09-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $45.82 | -2,320 | 111.0K | -2% | -$106.3K |
| DMT | 2025-09-04 | 2025-09-02+ | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $40.10 | -10.0K | 113.3K | -8% | -$401.0K |
| DMT | 2025-09-04 | 2025-09-02+ | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $6.67 | +10.0K | 116.5K | +9% | +$66.7K |
| T | 2025-06-18 | 2025-06-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $39.83 | -2,170 | 113.3K | -2% | -$86.4K |
| T | 2025-03-19 | 2025-03-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $39.04 | -1,864 | 115.0K | -2% | -$72.8K |
| D | 2025-03-04 | 2025-03-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | A - Grant | $0.00 | +20.4K | 116.9K | +21% | $0 |
| T | 2024-12-18 | 2024-12-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $45.40 | -2,635 | 96.5K | -3% | -$119.6K |
| DT | 2024-10-15 | 2024-10-11 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $2.68 | +10.0K | 108.9K | +10% | +$26.8K |
| DT | 2024-10-15 | 2024-10-11 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $50.30 | -10.0K | 98.9K | -9% | -$503.0K |
| T | 2024-09-18 | 2024-09-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $44.19 | -2,244 | 98.9K | -2% | -$99.2K |
| T | 2024-06-20 | 2024-06-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $37.39 | -1,893 | 101.2K | -2% | -$70.8K |
| DT | 2024-05-03 | 2024-05-03 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $40.03 | -10.0K | 102.0K | -9% | -$400.3K |
| DT | 2024-05-03 | 2024-05-03 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $2.68 | +10.0K | 112.0K | +10% | +$26.8K |
| T | 2024-03-20 | 2024-03-18 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $31.58 | -1,261 | 102.0K | -1% | -$39.8K |
| D | 2024-03-05 | 2024-03-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | A - Grant | $0.00 | +26.4K | 103.2K | +34% | $0 |
| T | 2023-12-20 | 2023-12-18 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $25.90 | -1,775 | 76.4K | -2% | -$46.0K |
| DM | 2023-10-23 | 2023-10-23 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $2.98 | +24.5K | 73.1K | +51% | +$73.0K |
| 2023-09-20 | 2023-09-18 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $31.31 | -1,427 | 53.7K | -3% | -$44.7K | |
| DT | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | M - OptEx | $2.68 | +20.0K | 75.1K | +36% | +$53.6K |
| DT | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale+OE | $35.05 | -20.0K | 55.1K | -27% | -$701.0K |
| 2023-06-22 | 2023-06-20 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $24.89 | -1,249 | 55.1K | -2% | -$31.1K | |
| 2023-03-21 | 2023-03-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $21.78 | -665 | 55.2K | -1% | -$14.5K | |
| D | 2023-03-03 | 2023-03-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | A - Grant | $0.00 | +26.6K | 55.9K | +91% | $0 |
| 2022-12-21 | 2022-12-19 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $22.94 | -658 | 29.3K | -2% | -$15.1K | |
| 2022-09-21 | 2022-09-19 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | S - Sale | $19.04 | -449 | 30.0K | -1% | -$8,549 | |
| D | 2022-09-02 | 2022-09-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | CFO | A - Grant | $0.00 | +10.0K | 30.4K | +49% | $0 |
| 2022-06-22 | 2022-06-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | See Remarks | S - Sale | $17.75 | -406 | 20.4K | -2% | -$7,206 | |
| 2022-03-21 | 2022-03-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | See Remarks | S - Sale | $18.62 | -159 | 19.9K | -0.8% | -$2,961 | |
| D | 2022-03-03 | 2022-03-01 | RVMD | Revolution Medicines, Inc. | Anders Jack | See Remarks | A - Grant | $0.00 | +11.6K | 20.0K | +138% | $0 |
| 2021-12-21 | 2021-12-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | See Remarks | S - Sale | $24.41 | -170 | 8,434 | -2% | -$4,150 | |
| 2021-09-21 | 2021-09-17 | RVMD | Revolution Medicines, Inc. | Anders Jack | See Remarks | S - Sale | $30.02 | -166 | 8,192 | -2% | -$4,983 |
Purchase Sale Sale after option exercise All abbreviations